North America Transdermal Drug Delivery System Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type; Application; End User- Product Image

Sale

North America Transdermal Drug Delivery System Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type; Application; End User

Report
160 Pages
August 2020
Region: North America
The Insight Partners
ID: 5147188

UP TO €1450EUR$1,500USD£1,246GBP OFF until Jun 30^th 2024

The North America transdermal drug delivery system market is expected to reach US$ 3,430.81 million by 2027 from US$ 2,422.34 million in 2019; it is estimated to grow at a CAGR of 4.6%from 2020 to 2027.

The growth of the market in North America is attributed to increasing prevalence of chronic diseases, growing demand for non-invasive drug delivery devices, and high preference for self-administration of drugs. However, the high cost of the development of drug delivery systems, and failure and recalls of transdermal drug delivery systems hinder the growth of the market.

In North America, the US in the largest market for transdermal drug delivery systems owing to rising prevalence of chronic diseases and increasing investments in R&D for the development of innovative drug delivery systems. Additionally, the presence of a large number of manufacturers with strong product portfolio, and increasing product approvals for the transdermal drug delivery systems are further driving the growth of the market in this country.

The North America transdermal drug delivery system market based on type is has been segmented into transdermal patch and transdermal semisolids. The market for the transdermal patch segment is subsegmented into drug-in-adhesive patches, matrix patches, reservoir membrane patches, and micro needle patches. The market for the transdermal semisolids segment is further segmented into gels, ointments, and sprays. The transdermal patch segment held a larger share of the market in 2019, and it is anticipated to register a higher CAGR during the forecast period. The North America transdermal drug delivery system market based on application has been segmented into cardiovascular diseases, central nervous system disorders, pain management, hormonal applications, and other applications. The market for hormonal applications is further segmented into transdermal estrogen therapy and testosterone replacement therapy. The pain management segment held the largest share of the market in 2019, and it is likely to register the highest CAGR during the forecast period. On the basis of end user, the transdermal drug delivery system market has been segmented into hospitals and clinics, home care settings, and other end users. The hospitals and clinics segment held the largest share of the market in 2019; however, the market for home care settings is expected grow at the highest CAGR during the forecast period.

A few major primary and secondary sources referred to in the process of preparing the report on the transdermal drug delivery system market in North America are the World Health Organization (WHO), Pharmaceutical Research and Manufacturers of America, and Centers for Disease Control and Prevention (CDC).

1. Introduction

1.1 Study Scope
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 North America Transdermal Drug Delivery System Market- By Type
1.3.2 North America Transdermal Drug Delivery System Market- By Application
1.3.3 North America Transdermal Drug Delivery System Market- By End User
1.3.4 North America Transdermal Drug Delivery System Market- By Region

2. Transdermal Drug Delivery System Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Transdermal Drug Delivery System - Market Landscape

4.1 Overview
4.2 PEST Analysis
4.2.1 North America
4.3 Expert Opinion

5. North America Transdermal Drug Delivery System Market - Industry Dynamics

5.1 Key Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Growing Demand for Non-Invasive Drug Delivery Devices
5.1.3 High Demand for Self-Administration of Drugs
5.2 Market Restraints
5.2.1 High Cost Involved in Development of Drug Delivery Systems
5.2.2 Drug Failure and Recalls of Transdermal Drug Delivery Systems
5.3 Market Opportunities
5.3.1 Strategic Activities by the Manufacturers
5.4 Future Trends
5.4.1 Rise in Adoption of Third-Generation Delivery Systems
5.5 Impact Analysis

6. Transdermal Drug Delivery System Market - Regional Analysis

6.1 North America Transdermal drug delivery system Market Revenue Forecast And Analysis

7. Transdermal Drug Delivery System Market Analysis - By Type

7.1 Overview
7.2 Transdermal Drug Delivery System Market Revenue Share, by Type, 2019 and 2027 (%)
7.2.1.1 North America Transdermal Patches Market, by Type - Revenue and Forecast to 2027 (USD Million)
7.3 Transdermal Patch
7.3.1 Overview
7.3.2 Transdermal Patch: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
7.3.3 Drug-In-Adhesive Patches
7.3.3.1 Overview
7.3.3.2 Drug-In-Adhesive Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
7.3.4 Matrix Patches
7.3.4.1 Overview
7.3.4.2 Matrix Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
7.3.5 Reservoir Membrane Patches
7.3.5.1 Overview
7.3.5.2 Reservoir Membrane Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
7.3.6 Microneedle Patches
7.3.6.1 Overview
7.3.6.2 Microneedle Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Transdermal Semisolids
7.4.1 Overview
7.4.2 Transdermal Semisolids: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Gel
7.5.1 Overview
7.5.2 Gel: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
7.6 Sprays
7.6.1 Overview
7.6.2 Sprays: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
7.7 Ointments
7.7.1 Overview
7.7.2 Ointments: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)

8. Transdermal Drug Delivery System Market - By Application

8.1 Overview
8.2 Transdermal Drug Delivery System Market, by Application, 2019 and 2027 (%)
8.2.1 North America Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2027 (USD Million)
8.3 Cardiovascular Diseases
8.3.1 Overview
8.3.2 Cardiovascular Diseases: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Central Nervous System Disorders
8.4.1 Overview
8.4.2 Central Nervous System Disorders: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Pain Management
8.5.1 Overview
8.5.2 Pain Management: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
8.6 Hormonal Applications
8.6.1 Overview
8.6.2 Hormonal Applications: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
8.6.3 Transdermal Estrogen Therapy
8.6.3.1 Overview
8.6.3.2 Transdermal Estrogen Therapy: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
8.6.4 Testosterone Replacement
8.6.4.1 Overview
8.6.4.2 Testosterone Replacement: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
8.7 Other Applications
8.7.1 Overview
8.7.2 Other Applications: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)

9. Transdermal Drug Delivery System Market - By End User

9.1 Overview
9.2 Transdermal Drug Delivery System Market, by End User, 2019 and 2027 (%)
9.2.1 North America Transdermal Drug Delivery System Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Home Care Settings
9.4.1 Overview
9.4.2 Home Care Settings: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Other End Users
9.5.1 Overview
9.5.2 Other End Users: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)
9.5.3 Other End Users: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (US$ Million)

10. Transdermal Drug Delivery System Market- Regional Analysis

10.1 North America: Transdermal Drug Delivery System Market
10.1.1 Overview
10.1.2 North America: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (USD Million)
10.1.3 North America Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.3.1 North America Transdermal Patches Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.3.2 North America Transdermal Semisolids Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.4 North America Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.1.4.1 North America Hormonal Applications Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.5 North America Transdermal Drug Delivery System Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.1.6 North America: Transdermal Drug Delivery System Market, by Country, 2019 & 2027 (%)
10.1.7 US: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.7.2.1 US Transdermal Patches Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.7.2.2 US Transdermal Semisolids Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.7.3 US Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.1.7.3.1 US Hormonal Applications Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.7.4 US Transdermal Drug Delivery System Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.1.8 Canada: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.8.2.1 Canada Transdermal Patches Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.8.2.2 Canada Transdermal Semisolids Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Canada Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.1.8.3.1 Canada Hormonal Applications Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.8.4 Canada Transdermal Drug Delivery System Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.1.9 Mexico: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.9.2.1 Mexico Transdermal Patches Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.9.2.2 Mexico Transdermal Semisolids Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.9.3 Mexico Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.1.9.3.1 Mexico Hormonal Applications Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.9.4 Mexico Transdermal Drug Delivery System Market, by End User - Revenue and Forecast to 2027 (USD Million)

11. Impact of COVID-19 Pandemic on North America Transdermal Drug Delivery System Market

11.1 North America: Impact assessment of COVID-19 Pandemic

12. Company Profiles

12.1 Johnson & Johnson Services, Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 MYLAN N.V.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Purdue Pharma L.P.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 GlaxoSmithKline plc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Bayer AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

13. Appendix

13.1 About the Publisher
13.2 Glossary of Terms

List of Tables

Table 1. North America Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 2. North America Transdermal Drug Delivery System Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 3. North America Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 4. North America Transdermal Drug Delivery System Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 5. North America Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 6. North America Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 7. North America Transdermal Drug Delivery System Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 8. North America Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 9. North America Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 10. US Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 11. US Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 12. US Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 13. US Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 14. US Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 15. US Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 16. Canada Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 17. Canada Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 18. Canada Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 19. Canada Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 20. Canada Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 21. Canada Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 22. Mexico Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 23. Mexico Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 24. Mexico Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 25. Mexico Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 26. Mexico Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 27. Mexico Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 28. Glossary of Terms, Transdermal Drug Delivery System Market

List of Figures

Figure 1. Transdermal Drug Delivery System Market Segmentation
Figure 2. Transdermal Drug Delivery System Segmentation – By Region
Figure 3. North America Transdermal Drug Delivery System Market Overview
Figure 4. Transdermal Patches Segment Held Largest Share of Transdermal Drug Delivery System Market
Figure 5. US Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. North America PEST Analysis
Figure 7. North America Transdermal Drug Delivery System Market – Revenue Forecast And Analysis – 2019- 2027
Figure 8. Transdermal Drug Delivery System Market Revenue Share, by Type, 2019 and 2027 (%)
Figure 9. Pharmaceutical: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 10. Drug-In-Adhesive Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Matrix Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Reservoir Membrane Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Microneedle Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Transdermal Semisolids: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Gel: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Sprays: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Ointments: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Transdermal Drug Delivery System Market, by Application, 2019 and 2027 (%)
Figure 19. Cardiovascular Diseases: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Central Nervous System Disorders: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Pain Management: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Hormonal Applications: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Transdermal Estrogen Therapy: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Testosterone Replacement: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. Other Applications: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Transdermal Drug Delivery System Market, by End User, 2019 and 2027 (%)
Figure 27. Hospitals and Clinics: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 28. Home Care Settings: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)
Figure 29. North America: Transdermal Drug Delivery System Market, by Key Country – Revenue (2019) (USD Million)
Figure 30. North America Transdermal Drug Delivery System Market Revenue and Forecast to 2027 (USD Million)
Figure 31. North America: Transdermal Drug Delivery System Market, by Country, 2019 & 2027 (%)
Figure 32. US: Transdermal Drug Delivery System market – Revenue and Forecast to 2027 (USD Million)
Figure 33. Canada: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)
Figure 34. Mexico: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)
Figure 35. Impact of COVID-19 Pandemic in North American Country Markets

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Johnson & Johnson Services, Inc.
Mylan N.V.
Purdue Pharma L.P.
GlaxoSmithKline plc
Bayer AG

PURCHASE OPTIONS

Single User License PDF

Site License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2030EUR$2,100USD£1,745GBP €2900EUR$3,000USD£2,493GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€2707EUR$2,800USD£2,327GBP €3867EUR$4,000USD£3,324GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€3384EUR$3,500USD£2,908GBP €4834EUR$5,000USD£4,155GBP

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

Global Transdermal Drug Delivery System Market by Type (Transdermal Patches, Transdermal Semisolids), Application (Cardiovascular Diseases, Central Nervous System Disorders, Hormonal Applications), End User - Forecast 2023-2030

Transdermal Drug Delivery System Market Size and Forecasts 2020 - 2030, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type, Application, and Distribution Channel

Global Transdermal Drug Delivery System Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Global Transdermal Drug Delivery Market 2024-2028

Transdermal Drug Delivery Systems Market Size, Share & Trends Analysis Report By Technology (Iontophoresis, Mechanical Arrays), By Application, By Region, And Segment Forecasts, 2024 - 2030